{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:51:48Z","timestamp":1782345108976,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T00:00:00Z","timestamp":1566000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Key R&D Program 2017 Project","award":["2017YFC0910101"],"award-info":[{"award-number":["2017YFC0910101"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ijid.2019.08.015","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T11:33:33Z","timestamp":1566300813000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP\/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia"],"prefix":"10.1016","volume":"88","author":[{"given":"Fan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-can","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7768-0767","authenticated-orcid":false,"given":"Zhang-ling","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2019.08.015_bib0005","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10096-005-0065-z","article-title":"Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation","volume":"25","author":"Annaloro","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2019.08.015_bib0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/thx.2010.135350","article-title":"A trial of caspofungin salvage treatment in PCP pneumonia","volume":"66","author":"Armstrong-James","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2019.08.015_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/QAI.0b013e31816de84d","article-title":"Second-line salvage treatment of aids-associated Pneumocystis jirovecii pneumonia: a case series and systematic review","volume":"48","author":"Benfield","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.ijid.2019.08.015_bib0020","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.transproceed.2016.05.017","article-title":"Risk evaluation and outcome of Pneumocystis jirovecii pneumonia in kidney transplant patients","volume":"48","author":"Brakemeier","year":"2016","journal-title":"Transplantation Proc"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.015_bib0025","doi-asserted-by":"crossref","first-page":"e8524","DOI":"10.1371\/journal.pone.0008524","article-title":"Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the Infection","volume":"5","author":"Cushion","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ijid.2019.08.015_bib0030","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/JCM.01554-13","article-title":"Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1-3)-\u03b2-D-Glucan for differential diagnosis of pneumocystis pneumonia and pneumocystis colonization","volume":"51","author":"Damiani","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.ijid.2019.08.015_bib0035","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.015_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1130-1406(09)70004-X","article-title":"Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005\u20132009)","volume":"26","author":"Ekholm","year":"2009","journal-title":"Rev Iberoam Micol"},{"issue":"7","key":"10.1016\/j.ijid.2019.08.015_bib0045","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1469-0691.2010.03452.x","article-title":"\u03b2-d-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia","volume":"17","author":"Held","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.ijid.2019.08.015_bib0050","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1086\/508282","article-title":"Progression of Pneumocystis jiroveci pneumonia in patients receiving echinocandin therapy","volume":"43","author":"Kamboj","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.015_bib0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1620\/tjem.217.117","article-title":"Measurement of (1-3)-beta-D-glucan derived from different gauze types","volume":"217","author":"Kanamori","year":"2009","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.015_bib0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12890-016-0307-0","article-title":"Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: a case report and literature review","volume":"16","author":"Li","year":"2016","journal-title":"Bmc Pulmonary Med"},{"issue":"35","key":"10.1016\/j.ijid.2019.08.015_bib0065","doi-asserted-by":"crossref","first-page":"59729","DOI":"10.18632\/oncotarget.19927","article-title":"Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ijid.2019.08.015_bib0070","doi-asserted-by":"crossref","first-page":"e70619","DOI":"10.1371\/journal.pone.0070619","article-title":"Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice","volume":"8","author":"Lobo","year":"2013","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.ijid.2019.08.015_bib0075","doi-asserted-by":"crossref","DOI":"10.1111\/myc.12642","article-title":"Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: a report of two cases and literature review","volume":"60","author":"Markantonatou","year":"2017","journal-title":"Mycoses"},{"issue":"7","key":"10.1016\/j.ijid.2019.08.015_bib0080","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3201\/eid0907.020753","article-title":"Sulfa resistance and dihydropteroate synthase mutants in recurrent, Pneumocystis carinii, Pneumonia","volume":"9","author":"Nahimana","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2019.08.015_bib0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijantimicag.2011.07.008","article-title":"Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief report","volume":"38","author":"Ngai","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2019.08.015_bib0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/crj.12042","article-title":"Clinical outcome and predictors of survival in patients with Pneumocystis jirovecii pneumonia-results of a tertiary referral centre","volume":"8","author":"Roembke","year":"2014","journal-title":"Clin Respir"},{"issue":"5","key":"10.1016\/j.ijid.2019.08.015_bib0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.medmal.2014.01.007","article-title":"Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients","volume":"44","author":"Roux","year":"2014","journal-title":"M\u00e9d Mal Infect"},{"issue":"5","key":"10.1016\/j.ijid.2019.08.015_bib0100","first-page":"1","article-title":"Caspofungin: pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes","volume":"42","author":"Song","year":"2015","journal-title":"Crit Rev Microbiol"},{"issue":"11","key":"10.1016\/j.ijid.2019.08.015_bib0105","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01737-13","article-title":"Point-Counterpoint: \u03b2-D-Glucan testing is important for diagnosis of invasive fungal infections","volume":"51","author":"Theel","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ijid.2019.08.015_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14787210.2017.1305887","article-title":"Diagnosis and management of Pneumocystis jirovecii infection","volume":"15","author":"White","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl. 11","key":"10.1016\/j.ijid.2019.08.015_bib0115","article-title":"The changing trends and profile of pneumocystosis mortality in the United States, 1999\u20132014","volume":"6","author":"Wickramasekaran","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.ijid.2019.08.015_bib0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/cdli.3.2.197-199.1996","article-title":"(1!3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia","volume":"3","author":"Yasuoka","year":"1996","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219303418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219303418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:46:52Z","timestamp":1761119212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219303418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":24,"alternative-id":["S1201971219303418"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.08.015","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP\/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}